ABT (Abbott Laboratories Inc.) Earnings per share for the trailing year

Public company logo of Abbott Labs (ABT)

The YoY growth in net income per share over the last 12 months demonstrates the scaling efficiency of glucose sensors at Abbott Laboratories (ABT), where the current status is -66.00. The company's strategy relies on expanding its portfolio of innovative monitoring systems to drive organic growth. Business stability is bolstered by a streamlined delivery network that ensures the integrity of high-precision instruments during transport to clinics.

Abbott Laboratories Inc. (ABT) Net earnings per share (EPS TTM): for the period 02/11/2024 - 11/15/2026

abbott.com - analytical breakdowns and key metrics (ABT)

- market value and analyst target forecast:
- business market valuation indicators:
Fundamental company valuation:Abbott Laboratories
Finished products of Abbott Laboratories

The market values Abbott Laboratories (ABT) as a stable asset with high capitalization potential. This indicator measures the percentage change in net earnings per share over the last twelve months, eliminating temporary reporting gaps. By analyzing the current state of annual EPS TTM growth, an investor can see the efficiency of R&D investments in glucose monitoring systems. Such metrics are characteristic of technological leaders within the healthcare sector.

Competitor analysis for Abbott Laboratories

Thermo Fisher Corp (TMO) - Net earnings per share for the last 12 months|GEHC: Net earnings per share (EPS TTM)|Mettler Toledo Inc - Earnings per share for the trailing year|Earnings per share for the last twelve months waters.com|TECH: Earnings per share for the trailing year|Earnings per share for the last twelve months Bruker Corp (BRKR)|Net earnings per share for the last 12 months Azenta AZTA|Net earnings per share (EPS TTM) VREX (vareximaging.com)|Semler Scientific Corp (SMLR) - Net earnings per one share for the last twelve months|Butterfly Network - Net earnings per share (EPS TTM)|MLAB (Mesa Laboratories, Inc.) - Earnings per share for the last 12 months|QSI: Net earnings per share (EPS TTM)|NNOX - Net earnings per share for the last four quarters|QTRX (Quanterix Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months 908 Devices Corp (MASS)|Net earnings per share for the last 12 months CV (CapsoVision, Inc.)|Net earnings per share (EPS TTM) maxcyte.com (MXCT)|Earnings per share for the last twelve months Rapid Micro RPID|Seer Inc. - Earnings per share for the last twelve months|HYPR: Net earnings per share for the last 12 months|Earnings per share for the trailing year FONR (FONAR Corp)|Daxor Corp (DXR) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months spectral-ai.com (MDAI)|Earnings per share for the last twelve months VivoSim Labs|ACON - Net earnings per share for the trailing year|Net earnings per share for the last 12 months AKYA (akoyabio.com)|Net earnings per share (EPS TTM) ThermoGenesis Holdings Inc. (THMO)|Net earnings per share (EPS TTM) TLIS (talis.bio)|Net earnings per share for the last four quarters t2biosystems.com (TTOO)